Article
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study
2022-05-20
Abstract excerpt
<h4>Summary</h4> <h4>Background</h4> Effectiveness of oral antivirals in mild-to-moderate COVID-19 patients is urgently needed. This retrospective cohort study aims to evaluate the clinical and virologic outcomes associated with molnupiravir and nirmatrelvir/ritonavir use in COVID-19 patients during a pandemic wave dominated by the Omicron BA.2 subvariant. <h4>Methods</h4> We analyzed data from a territory-wide re...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c5f2a53c-f935-5b5a-813a-ef436d410298
- DOI
- 10.1101/2022.05.19.22275291
